Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions
Pharmacoepidemiology and Drug Safety2005Vol. 14(11), pp. 755–767
Citations Over TimeTop 10% of 2005 papers
Abstract
Potential fluconazole drug interactions were very frequent among hospitalized patients on systemic azole antifungal therapy, but they had few apparent clinical consequences.
Related Papers
- → Itraconazole: Pharmacologic Studies in Animals and Humans(1987)131 cited
- → R 51211 (itraconazole) therapy of murine cryptococcosis(1984)35 cited
- → Itraconazole Versus Ketoconazole for the Prophylaxis of Fungal Infection in Neutropenic Children: Results of Two Consecutive Nonrandomized Studies(1989)6 cited
- [Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].(1990)
- [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].(1990)